330 related articles for article (PubMed ID: 28091594)
21. Functional role of RBM10 in lung adenocarcinoma proliferation.
Sun X; Jia M; Sun W; Feng L; Gu C; Wu T
Int J Oncol; 2019 Feb; 54(2):467-478. PubMed ID: 30483773
[TBL] [Abstract][Full Text] [Related]
22. Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma.
Rao W; Yang L; Dai N; Zhang L; Liu J; Yang B; Li M; Shan J; Wang Q; Wang D
Clin Transl Oncol; 2023 Jun; 25(6):1767-1778. PubMed ID: 36739576
[TBL] [Abstract][Full Text] [Related]
23. Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation.
Wang Y; Gogol-Döring A; Hu H; Fröhler S; Ma Y; Jens M; Maaskola J; Murakawa Y; Quedenau C; Landthaler M; Kalscheuer V; Wieczorek D; Wang Y; Hu Y; Chen W
EMBO Mol Med; 2013 Sep; 5(9):1431-42. PubMed ID: 24000153
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis.
He RQ; Gao L; Ma J; Li ZY; Hu XH; Chen G
Oncol Rep; 2018 Jul; 40(1):83-100. PubMed ID: 29749535
[TBL] [Abstract][Full Text] [Related]
25. A novel circular RNA, circXPO1, promotes lung adenocarcinoma progression by interacting with IGF2BP1.
Huang Q; Guo H; Wang S; Ma Y; Chen H; Li H; Li J; Li X; Yang F; Qiu M; Zhao S; Wang J
Cell Death Dis; 2020 Dec; 11(12):1031. PubMed ID: 33268793
[TBL] [Abstract][Full Text] [Related]
26. RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma.
Liu B; Wang Y; Wang H; Li Z; Yang L; Yan S; Yang X; Ma Y; Gao X; Guan Y; Yi X; Xia X; Li J; Wu N
Front Oncol; 2021; 11():677826. PubMed ID: 34367963
[TBL] [Abstract][Full Text] [Related]
27. PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.
Mao S; Li Y; Lu Z; Che Y; Huang J; Lei Y; Wang Y; Liu C; Wang X; Zheng S; Sun N; He J
Cancer Med; 2019 May; 8(5):2429-2441. PubMed ID: 30932358
[TBL] [Abstract][Full Text] [Related]
28. miR-335 modulates Numb alternative splicing via targeting RBM10 in endometrial cancer.
Dou XQ; Chen XJ; Zhou Q; Wen MX; Zhang SZ; Zhang SQ
Kaohsiung J Med Sci; 2020 Mar; 36(3):171-177. PubMed ID: 31894898
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer.
Nanjo S; Wu W; Karachaliou N; Blakely CM; Suzuki J; Chou YT; Ali SM; Kerr DL; Olivas VR; Shue J; Rotow J; Mayekar MK; Haderk F; Chatterjee N; Urisman A; Yeo JC; Skanderup AJ; Tan AC; Tam WL; Arrieta O; Hosomichi K; Nishiyama A; Yano S; Kirichok Y; Tan DS; Rosell R; Okimoto RA; Bivona TG
J Clin Invest; 2022 Jul; 132(13):. PubMed ID: 35579943
[TBL] [Abstract][Full Text] [Related]
30. Co- and post-transcriptional regulation of Rbm5 and Rbm10 in mouse cells as evidenced by tissue-specific, developmental and disease-associated variation of splice variant and protein expression levels.
Ozuemba B; Masilamani TJ; Loiselle JJ; Koenderink B; Vanderbeck KA; Knee J; Larivière C; Sutherland LC
Gene; 2016 Apr; 580(1):26-36. PubMed ID: 26784654
[TBL] [Abstract][Full Text] [Related]
31. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD).
Wu L; Liu Q; Ruan X; Luan X; Zhong Y; Liu J; Yan J; Li X
Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509501
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive molecular profiling of lung adenocarcinoma.
Cancer Genome Atlas Research Network
Nature; 2014 Jul; 511(7511):543-50. PubMed ID: 25079552
[TBL] [Abstract][Full Text] [Related]
33. Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancer.
Dou XQ; Chen XJ; Wen MX; Zhang SZ; Zhou Q; Zhang SQ
Kaohsiung J Med Sci; 2020 Jan; 36(1):13-19. PubMed ID: 31587503
[TBL] [Abstract][Full Text] [Related]
34. Rbm10 regulates inflammation development via alternative splicing of Dnmt3b.
Atsumi T; Suzuki H; Jiang JJ; Okuyama Y; Nakagawa I; Ota M; Tanaka Y; Ohki T; Katsunuma K; Nakajima K; Hasegawa Y; Ohara O; Ogura H; Arima Y; Kamimura D; Murakami M
Int Immunol; 2017 Dec; 29(12):581-591. PubMed ID: 29309623
[TBL] [Abstract][Full Text] [Related]
35. RBM10 regulates alternative splicing.
Inoue A; Yamamoto N; Kimura M; Nishio K; Yamane H; Nakajima K
FEBS Lett; 2014 Mar; 588(6):942-7. PubMed ID: 24530524
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
37. Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival.
Fei DL; Motowski H; Chatrikhi R; Prasad S; Yu J; Gao S; Kielkopf CL; Bradley RK; Varmus H
PLoS Genet; 2016 Oct; 12(10):e1006384. PubMed ID: 27776121
[TBL] [Abstract][Full Text] [Related]
38. RBM10 regulates centriole duplication in HepG2 cells by ectopically assembling PLK4-STIL complexes in the nucleus.
Kunimoto H; Inoue A; Kojima H; Yang J; Zhao H; Tsuruta D; Nakajima K
Genes Cells; 2020 Feb; 25(2):100-110. PubMed ID: 31820547
[TBL] [Abstract][Full Text] [Related]
39. Integrative analysis of genomic sequencing data reveals higher prevalence of LRP1B mutations in lung adenocarcinoma patients with COPD.
Xiao D; Li F; Pan H; Liang H; Wu K; He J
Sci Rep; 2017 May; 7(1):2121. PubMed ID: 28522810
[TBL] [Abstract][Full Text] [Related]
40. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
Liu B; Chen Y; Yang J
Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
